Impact of a Dietary Supplementation with French Maritime Pine Bark Extract Pycnogenol® on Salivary and Serum Inflammatory Biomarkers During Non-Surgical Periodontal Therapy—A Randomized Placebo-Controlled Double-Blind Trial
Nutrients · 2025
DOI: 10.3390/nu17091546 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Jasmin Bayer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy and Food Chemistry, University of Würzburg, 97074 Würzburg, Germany. Hauptthemen laut MEDLINE: Flavonoids, Saliva, Dietary Supplements, Plant Extracts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horphag Research.
Abstract (Originalsprache)
Background
Gingival inflammation is highly prevalent and may impact systemic health. While professional mechanical plaque removal (PMPR) is the standard treatment, dietary interventions may provide additional benefits. The French maritime pine bark extract Pycnogenol® has anti-inflammatory and antioxidant properties, but its impact on inflammatory biomarkers in saliva and serum has not been studied in a controlled clinical trial.
Methods
In this randomized, double-blind, placebo-controlled clinical trial, 91 participants received Pycnogenol® (100 mg twice daily; n = 46) or a placebo (n = 45) following PMPR. Saliva and serum samples were collected at baseline, and after two and three months. Inflammatory biomarkers (IL-1β, IL-6, MMP-8, and MMP-9) and polyphenol concentrations were analyzed using ELISA and LC-MS/MS.
Results
Pycnogenol® supplementation significantly reduced salivary MMP-8 levels (p = 0.0261), and serum IL-6 levels compared to placebo (p = 0.0409). Additionally, ferulic acid, caffeic acid, and the gut microbial metabolite 5-(3,4-dihydroxyphenyl)-γ-valerolactone (M1) significantly increased in saliva following Pycnogenol® intake. A correlation analysis revealed a significant inverse association between bleeding on probing and M1 concentration in saliva (r = −0.3476, p = 0.0167).
Conclusions
Dietary supplementation with Pycnogenol® significantly reduced key inflammatory biomarkers and increased polyphenol concentrations in saliva, suggesting a potential anti-inflammatory effect of Pycnogenol® on gingival inflammation.
Trial registration
ClinicalTrials.gov (NCT05786820).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacy and Food Chemistry, University of Würzburg, 97074 Würzburg, Germany.
- Department of Periodontology, University Hospital Würzburg, 97070 Würzburg, Germany.
ORCID-Profile: Yvonne Jockel-Schneider, Petra Högger
Förderung
- Horphag Research
Zitieren
APA
Bayer, J., Petersen, N. K., Hess, J. V., Jockel-Schneider, Y., & Högger, P. (2025). Impact of a Dietary Supplementation with French Maritime Pine Bark Extract Pycnogenol® on Salivary and Serum Inflammatory Biomarkers During Non-Surgical Periodontal Therapy—A Randomized Placebo-Controlled Double-Blind Trial. Nutrients. https://doi.org/10.3390/nu17091546
Vancouver
Bayer J, Petersen NK, Hess JV, Jockel-Schneider Y, Högger P. Impact of a Dietary Supplementation with French Maritime Pine Bark Extract Pycnogenol® on Salivary and Serum Inflammatory Biomarkers During Non-Surgical Periodontal Therapy—A Randomized Placebo-Controlled Double-Blind Trial. Nutrients. 2025. doi:10.3390/nu17091546
BibTeX
@article{Bayer2025,
author = {Bayer, Jasmin and Petersen, Nicole Karoline and Hess, Jeanine Veruschka and Jockel-Schneider, Yvonne and Högger, Petra},
title = {Impact of a Dietary Supplementation with French Maritime Pine Bark Extract Pycnogenol® on Salivary and Serum Inflammatory Biomarkers During Non-Surgical Periodontal Therapy—A Randomized Placebo-Controlled Double-Blind Trial},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17091546}
}
EUVIMED